Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II

BMC Biochemistry

Volumn 4, Issue , 2003, Pages 1-16

  Liu, Jie ^a   Rothermund, Christy A ^a   Ayala Sanmartin, Jesus ^b   Vishwanatha, Jamboor K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 2; MUTANT PROTEIN; PHOSPHOPROTEIN; CELL RECEPTOR; EXPORTIN 1 PROTEIN; GLUTAMIC ACID; KARYOPHERIN; SERINE; SIGNAL PEPTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; NUCLEOCYTOPLASMIC TRANSPORT; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; WILD TYPE; ACTIVE TRANSPORT; CELL CYCLE; CELL DIVISION; CHEMISTRY; GENETICS; MALE; METABOLISM; MUTATION; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

NES;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SUBSTITUTION; ANNEXIN A2; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; GLUTAMIC ACID; HUMANS; KARYOPHERINS; MALE; MUTATION; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN SORTING SIGNALS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SERINE;

EID: 2942696333     PISSN: 14712091     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2091-4-10     Document Type: Article

References (68)

1. Geisow MJ, Walker JH, Boustead C and Taylor W: Annexins - new family of Ca2+-regulated-phospholipid binding protein. Biosci Rep 1987, 7:289-298.
2. Gerke V and Weber K: Identity of p36K phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush borders; calcium-dependent binding to non-erythroid spectrin and F-actin. EMBO J 1984, 3:227-233.
3. Thiel C, Osborn M and Gerke V: The tight association of the tyrosine kinase substrate annexin II with the submembra-nous cytoskeleton depends on intact p11- and Ca(2+)-binding sites. J Cell Sci 1992, 103 (Pt 3):733-742.
4. Ali SM, Geisow MJ and Burgoyne RD: A role for calpactin in calcium-dependent exocytosis in adrenal chromaffin cells. Nature 1989, 340:313-315.
5. Creutz CE: The annexins and exocytosis. Science 1992, 258:924-931.
6. Sarafian T, Pradel LA, Henry JP, Aunis D and Bader MF: The participation of annexin II (calpactin I) in calcium-evoked exocytosis requires protein kinase C. J Cell Biol 1991, 114:1135-1147.
7. Chasserot-Golaz S, Vitale N, Sagot I, Delouche B, Dirrig S, Pradel LA, Henry JP, Aunis D and Bader MF: Annexin II in exocytosis: catecholamine secretion requires the translocation of p36 to the subplasmalemmal region in chromaffin cells. J Cell Biol 1996, 133:1217-1236.
8. Munz B, Gerke V, Gillitzer R and Werner S: Differential expression of the calpactin I subunits annexin II and p11 in cultured keratinocytes and during wound repair. J Invest Dermatol 1997,108:307-312.
9. Zokas L and Glenney-JR Jr: The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: studies using monoclonal antibodies to calpactin subunits. J Cell Biol 1987, 105:2111-2121.
10. Jindal HK and Vishwanatha JK: Purification and characterization of primer recogniton proteins from HeLa cells. Biochemistry 1990, 29:4767-4773.
11. Jindal HK, Chaney WG, Anderson CW, Davis RG and Vishwanatha JK: The protein-tyrosine kinase substrate, calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase a. Journal of Biological Chemistry 1991, 266:5169-5176.
12. Vishwanatha JK and Kumble S: Involvement of annexin II in DNA replication: evidence from cell-free extracts of Xenopus eggs. Journal of Cell Science 1993, 105:533-540.
13. Kumble KD, Iversen PL and Vishwanatha JK: The role of primer recognition proteins in DNA replication: Inhibition of cellular proliferation by antisense oligodeoxyribonucleotides. Journal of Cell Science 1992, 101:35-41.
14. Chiang Y, Rizzino A, Sibenaller ZA, Wold MS and Vishwanatha JK: Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem 1999, 199:139-147.
15. Johnsson N, Nguyen Van P., Soling HD and Weber K: Functionally distinct serine phosphorylation sites of p36, the cellular substrate of retroviral protein kinase; differential inhibition of reassociation with p11. EMBO J 1986, 5:3455-3460.
16. Regnouf F, Sagot I, Delouche B, Devilliers G, Cartaud J, Henry JP and Pradel LA: "In vitro " phosphorylation of annexin 2 heterote-tramer by protein kinase C - Comparative properties of the unphosphorylated and phosphorylated annexin 2 on the aggregation and fusion of chromaffin granule membranes. Journal of Biological Chemistry 1995, 270:27143-27150.
17. Glenney J.R.,Jr. and Tack BF: Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. Proc Natl Acad Sci U S A 1985, 82:7884-7888.
18. Powell MA and Glenney JR: Regulation of calpactin I phospholiped binding by calpactin I light-chain binding and phosphorylation by p60v-src. Biochemistry Journal 1987, 247:321-328.
19. Johnstone SA, Hubaishy I and Waisman DM: Phosphorylation of annexin II tetramer by protein kinase C inhibits aggregation of lipid vesicles by the protein. Journal of Biological Chemistry 1992, 267:25976-25981.
20. Chetcuti A, Margan SH, Russell P, Mann S, Millar DS, Clark SJ, Rogers J, Handelsman DJ and Dong Q: Loss of annexin ii heavy and light chains in prostate cancer and its precursors. Cancer Res 2001, 61:6331-6334.
21. Andronicos NM and Ranson M: The topology of plasminogen binding and activation on the surface of human breast cancer cells. Br J Cancer 2001, 85:909-916.
22. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG and Hanash SM: An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 2001, 98:9824-9829.
23. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S and Nakajima Y: Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 2001, 92:1419-1426.
24. Choi S, Kobayashi M, Wang J, Habelhah H, Okada F, Hamada J, Moriuchi T, Totsuka Y and Hosokawa M: Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin. Clin Exp Metastasis 2000, 18:45-50.
25. Kaczan-Bourgois D, Salles JP and Chap H: Expression of annexin II and associated p11 protein by differentiated choriocarcinoma Jar cells. Am J Obstet Gynecol 1999, 181:1273.
26. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA and Hajjar KA: Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 1999, 340:994-1004.
27. Balch C and Dedman JR: Annexins II and V inhibit cell migration. Exp Cell Res 1997, 237:259-263.
28. Blanchard S, Barwise JL, Gerke V, Goodall A, Vaughan PF and Walker JH: Annexins in the human neuroblastoma SH-SY5Y: demonstration of relocation of annexins II and V to membranes in response to elevation of intracellular calcium by membrane depolarisation and by the calcium ionophore A23187. J Neurochem 1996, 67:805-813.
29. Mohiti J, Walker JH and Caswell AM: Studies on annexins in primary cultures of human osteoblasts and in the human osteosarcoma cell line MG-63. Biochem Soc Trans 1995, 23:36S.
30. Roseman BJ, Bollen A, Hsu J, Lamborn K and Israel MA: Annexin II marks astrocytic brain tumors of high histologic grade. Oncol Res 1994, 6:561-567.
31. Tressler RJ, Updyke TV, Yeatman T and Nicolson GL: Extracellular annexin II is associated with divalent cation- dependent tumor cell-endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. Journal of Cellular Biochemistry 1993, 53:265-276.
32. Ozaki T and Sakiyama S: Molecular cloning of rat calpactin I heavy-chain cDNA whose expression is induced in v-src-transformed rat culture cell lines. Oncogene 1993, 8:1707-1710.
33. Fox MT, Prentice DA and Hughes JP: Increases in p11 and annexin II proteins correlate with differentiation in the PC12 pheochromocytoma. Biochemical and Biophysical Research Communications 1991, 177:1188-1193.
34. Gress TM, Wallrapp C, Frohme M, Muller Pillasch F., Lacher U, Friess H, Buchler M, Adler G and Hoheisel JD: Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis. Genes Chromosomes Cancer 1997, 19:97-103.
35. Manda R, Kohno T, Matsuno Y, Takenoshita S, Kuwano H and Yokota J: Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. Genomics 1999, 61:5-14.
36. Nygaard SJ, Haugland HK, Kristoffersen EK, Lund Johansen M., Laerum OD and Tysnes OB: Expression of annexin II in glioma cell lines and in brain tumor biopsies. J Neurooncol 1998, 38:11-18.
37. Cole SPC, Pinkoski MJ, Bhardwaj G and Deeley RG: Elevated expression of Annexin II (Lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. British Journal of Cancer 1992, 65:498-502.
38. Kumble KD, Hirota M, Pour PM and Vishwanatha JK: Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. Cancer Research 1992, 52:163-167.
39. Vishwanatha JK, Chiang Y, Kumble KD, Hollingsworth MA and Pour PM: Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 1993, 14:2575-2579.
40. Eberhard DA, Karns LR, VandenBerg SR and Creutz CE: Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J Cell Sci 2001, 114:3155-3166.
41. Engel K, Kotlyarov A and Gaestel M: Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J 1998, 17:3363-3371.
42. Zhang Y and Xiong Y: A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 2001, 292:1910-1915.
43. Ayala-Sanmartin J, Gouache P and Henry JP: N-Terminal domain of annexin 2 regulates Ca(2+)-dependent membrane aggregation by the core domain: a site directed mutagenesis study. Biochemistry 2000, 39:15190-15198.
44. Chiang Y, Schneiderman MH and Vishwanatha JK: Annexin II expression is regulated during mammalian cell cycle. Cancer Research 1993, 53:6017-6021.
45. Keutzer JC and Hirschhorn RR: The growth-regulated gene 1B6 is identified as the heavy chain of calpactin I. Exp Cell Res 1990, 188:153-159.
46. Rothermund CA, Kondrikov D, Lin MF and Vishwanatha JK: Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer. Prostate Cancer Prostatic Dis 2002, 5:236-245.
47. Frisa PS and Jacobberger JW: Cell density related gene expression: SV40 large T antigen levels in immortalized astrocyte lines. BMC Cell Biol 2002, 3:10.
48. Chiang Y, Davis RG and Vishwanatha JK: Altered expression of annexin II in human B-cell lymphoma cell lines. Biochim Biophys Acta 1996, 1313:295-301.
49. Saha P, Chen J, Thome KC, Lawlis SJ, Hou ZH, Hendricks M, Parvin JD and Dutta A: Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase. Mol Cell Biol 1998, 18:2758-2767.
50. Gould KL, Woodgett JR, Isacke CM and Hunter T: The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol Cell Biol 1986, 6:2738-2744.
51. Jost M and Gerke V: Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II. Biochim Biophys Acta 1996, 1313:283-289.
52. Sarafian T, Pradel L-A, Henry J-P, Aunis D and Bader M-F: The participation of annexin II (calpactin I) in calcium- evoked exocytosis requires protein kinase C. Journal of Cell Biology 1991, 114:1135-1147.
53. Sagot I, Regnouf F, Henry JP and Pradel LA: Translocation of cytosolic annexin 2 to a Triton-insoluble membrane subdomain upon nicotine stimulation of chromaffin cultured cells. FEBS Lett 1997, 410:229-234.
54. Karasik A, Pepinsky RB, Shoelson SE and Kahn CR: Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. J Biol Chem 1988, 263:11862-11867.
55. Kelly TJ and Brown GW: Regulation of chromosome replication. Annu Rev Biochem 2000, 69:829-880.
56. Dupont S, Sharova N, DeHoratius C, Virbasius CM, Zhu X, Bukrinskaya AG, Stevenson M and Green MR: A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 1999, 402:681-685.
57. Kudo N, Khochbin S, Nishi K, Kitano K, Yanagida M, Yoshida M and Horinouchi S: Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins. J Biol Chem 1997, 272:29742-29751.
58. Wen W, Meinkoth JL, Tsien RY and Taylor SS: Identification of a signal for rapid export of proteins from the nucleus. Cell 1995, 82:463-473.
59. Delmolino LM, Saha P and Dutta A: Multiple mechanisms regulate subcellular localization of human CDC6. J Biol Chem 2001, 276:26947-26954.
60. Pol A, Ortega D and Enrich C: Identification of cytoskeleton-associated proteins in isolated rat liver endosomes. Biochem J 1997, 327 (Pt 3):741-746.
61. Gerke V and Moss SE: Annexins and membrane dynamics. Biochim Biophys Acta 1997, 1357:129-154.
62. Ikebuchi NW and Waisman DM: Calcium-dependent regulation of actin filament bundling by lipocortin-85. J Biol Chem 1990, 265:3392-3400.
63. Liu JW, Shen JJ, Tanzillo-Swarts A, Bhatia B, Maldonado CM, Person MD, Lau SS and Tang DG: Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 2003, 22:1475-1485.
64. Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Rank F, Niebuhr E, Bissell MJ and Ronnov-Jessen L: Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol 2003, 162:391-402.
65. Komeili A and O'Shea EK: Roles of phosphorylation sites in regulating activity of the transcription factor Pho4. Science 1999, 284:977-980.
66. Zhu J, Shibasaki F, Price R, Guillemot JC, Yano T, Dotsch V, Wagner G, Ferrara P and McKeon F: Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell 1998, 93:851-861.
67. Pepinsky RB, Sinclair LK, Chow EP and O'Brine-Greco B: A dimeric form of lipocortin-1 in human placenta. Biochem J 1989, 263:97-103.
68. Pradel LA and Rendon A: Annexin 1 is present in different molecular forms in rat cerebral cortex. FEBS Letters 1993, 327:41-44.